MeSH D003967 - diarrhea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Able Laboratories | Loperamide | Loperamide | 1993-11-30 | |||
| ALK-Abelló | Ciprofloxacin | Otiprio | 2029-04-21 | 2015-12-10 | ||
| Alkem Laboratories | Colesevelam | Colesevelam | 2018-10-05 | |||
| Vancomycin | Vancomycin | 2022-11-14 | ||||
| Allergan | Eluxadoline | Truberzi | 2016-09-19 | |||
| Ciprofloxacin | Ciprofloxacin | 2005-01-21 | ||||
| Colesevelam | Colesevelam | 2020-09-02 | ||||
| Loperamide | Loperamide | 1993-05-28 | ||||
| Vancomycin | Vancomycin | 2012-04-09 | ||||
| Alpharma | Loperamide | Loperamide | 1992-09-15 | |||
| Altaire Pharmaceuticals | Ciprofloxacin | Ciprofloxacin | 2018-05-03 |
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
54%7/13
Phase 2
47%20/43
Phase 3
70%35/50
Approved: 19Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use